TY - JOUR T1 - An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain JO - Journal of Bone Oncology UR - http://eprints.whiterose.ac.uk/151202/ PY - 2019/09/18 AU - Danson S AU - Mulvey MR AU - Turner L AU - Horsman J AU - Escott KJ AU - Coleman RE AU - Ahmedzai SH AU - Bennett MI AU - Andrew D ED - DO - DOI: 10.1016/j.jbo.2019.100261 PB - Elsevier Y2 - 2025/05/08 ER -